Daiichi Jitsugyo Co (8059) Q1 2026 earnings summary

Executive summary

• Achieved record-high net sales and profits at every stage for Q1, with net sales rising 14.1% year-over-year to ¥49,489 million, driven by large-scale sales in the Healthcare Business.

• Operating income increased 19.2% year-over-year to ¥2,501 million.

• Profit attributable to owners of parent surged 60.9% year-over-year to ¥1,745 million.

• Basic earnings per share grew to ¥54.74, up 20.53 yen year-over-year.

• Progress toward full-year financial forecasts is ahead of pace at 20.3% for profit attributable to owners of parent.

Financial highlights

• Net sales rose by 6.117 billion yen year-over-year to 49.489 billion yen.

• Gross profit increased to ¥8,609 million from ¥7,920 million year-over-year.

• Ordinary income climbed 35.6% year-over-year to ¥2,488 million.

• Comprehensive income for the quarter was ¥2,008 million, down 5.7% year-over-year.

• EPS reached 54.74 yen, up 20.53 yen year-over-year.

Outlook and guidance

• Full-year net sales forecast at ¥220,000 million, a 0.8% decrease year-over-year.

• Operating income projected at ¥12,000 million, down 9.5% year-over-year.

• Profit attributable to owners of parent expected at ¥8,600 million, a 2.7% decrease year-over-year.

• Basic earnings per share forecasted at ¥269.64.

• Annual dividend forecast is 108 yen per share, with an interim forecast of 51 yen.